These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 17383644)

  • 21. Morphology and Immunohistochemistry for 2SC and FH Aid in Detection of Fumarate Hydratase Gene Aberrations in Uterine Leiomyomas From Young Patients.
    Joseph NM; Solomon DA; Frizzell N; Rabban JT; Zaloudek C; Garg K
    Am J Surg Pathol; 2015 Nov; 39(11):1529-39. PubMed ID: 26457356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fumarate hydratase deficient renal cell carcinoma and fumarate hydratase deficient-like renal cell carcinoma: Morphologic comparative study of 23 genetically tested cases.
    Pivovarčíková K; Martínek P; Trpkov K; Alaghehbandan R; Magi-Galluzzi C; Mundo EC; Berney D; Suster S; Gill A; Rychlý B; Michalová K; Pitra T; Hora M; Michal M; Hes O
    Cesk Patol; 2019; 55(4):244-249. PubMed ID: 31842557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MR Spectroscopy for Detecting Fumarate Hydratase Deficiency in Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome.
    Wu G; Liu G; Wang J; Pan S; Luo Y; Xu Y; Kong W; Sun P; Xu J; Xue W; Zhang J
    Radiology; 2022 Dec; 305(3):631-639. PubMed ID: 35943337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Uterine smooth muscle tumors with features suggesting fumarate hydratase aberration: detailed morphologic analysis and correlation with S-(2-succino)-cysteine immunohistochemistry.
    Reyes C; Karamurzin Y; Frizzell N; Garg K; Nonaka D; Chen YB; Soslow RA
    Mod Pathol; 2014 Jul; 27(7):1020-7. PubMed ID: 24309325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hereditary leiomyomatosis and renal cell cancer - HLRCC/multiple cutaneous and uterine leimomyomatosis - MCUL].
    Plevová P; Hladíková A; Tesařová M
    Klin Onkol; 2012; 25 Suppl():S55-8. PubMed ID: 22920208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expanding morphological and clinical aspects of hereditary leiomyomatosis and renal cell carcinoma (HLRCC): a case report in a patient with unusual morphology and clinical presentation.
    da Cunha IW; da Costa WH; Morini MA; Bezerra SM; Carraro DM; Torrezan GT; Formiga MNC; Guimaraes GC; Zequi SC; Soares FA
    Virchows Arch; 2018 Dec; 473(6):775-779. PubMed ID: 30171332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heterogeneous adaptation of cysteine reactivity to a covalent oncometabolite.
    Perez M; Bak DW; Bergholtz SE; Crooks DR; Arimilli BS; Yang Y; Weerapana E; Linehan WM; Meier JL
    J Biol Chem; 2020 Sep; 295(39):13410-13418. PubMed ID: 32820045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fumarate hydratase gene mutation in two young patients with sporadic uterine fibroids.
    Kubinova K; Tesarova M; Hansikova H; Vesela K; Kuzel D; Mara M
    J Obstet Gynaecol Res; 2013 Jan; 39(1):410-4. PubMed ID: 22764886
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hereditary leiomyomatosis and renal cell cancer syndrome associated renal cell carcinoma.
    Adamane S; Desai S; Menon S
    Indian J Pathol Microbiol; 2017; 60(1):108-110. PubMed ID: 28195105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biallelic inactivation of fumarate hydratase (FH) occurs in nonsyndromic uterine leiomyomas but is rare in other tumors.
    Lehtonen R; Kiuru M; Vanharanta S; Sjöberg J; Aaltonen LM; Aittomäki K; Arola J; Butzow R; Eng C; Husgafvel-Pursiainen K; Isola J; Järvinen H; Koivisto P; Mecklin JP; Peltomäki P; Salovaara R; Wasenius VM; Karhu A; Launonen V; Nupponen NN; Aaltonen LA
    Am J Pathol; 2004 Jan; 164(1):17-22. PubMed ID: 14695314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Strong family history of uterine leiomyomatosis warrants fumarate hydratase mutation screening.
    Tolvanen J; Uimari O; Ryynänen M; Aaltonen LA; Vahteristo P
    Hum Reprod; 2012 Jun; 27(6):1865-9. PubMed ID: 22473397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hereditary leiomyomatosis and renal cell cancer: a syndrome associated with an aggressive form of inherited renal cancer.
    Grubb RL; Franks ME; Toro J; Middelton L; Choyke L; Fowler S; Torres-Cabala C; Glenn GM; Choyke P; Merino MJ; Zbar B; Pinto PA; Srinivasan R; Coleman JA; Linehan WM
    J Urol; 2007 Jun; 177(6):2074-9; discussion 2079-80. PubMed ID: 17509289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Review: Warburg effect and renal cancer caused by errs in fumarate hydratase encoding gene.
    Qureshi AS; Ali S
    Pak J Pharm Sci; 2019 Mar; 32(2):743-749. PubMed ID: 31081789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein profiling of blood samples from patients with hereditary leiomyomatosis and renal cell cancer by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
    Kamai T; Tomosugi N; Abe H; Kaji Y; Oyama T; Yoshida K
    Int J Mol Sci; 2012 Nov; 13(11):14518-32. PubMed ID: 23203078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and molecular genetic aspects of hereditary multiple cutaneous leiomyomatosis.
    Badeloe S; Frank J
    Eur J Dermatol; 2009; 19(6):545-51. PubMed ID: 19939761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hereditary leiomyomatosis and renal cell cancer in families referred for fumarate hydratase germline mutation analysis.
    Smit DL; Mensenkamp AR; Badeloe S; Breuning MH; Simon ME; van Spaendonck KY; Aalfs CM; Post JG; Shanley S; Krapels IP; Hoefsloot LH; van Moorselaar RJ; Starink TM; Bayley JP; Frank J; van Steensel MA; Menko FH
    Clin Genet; 2011 Jan; 79(1):49-59. PubMed ID: 20618355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mitochondrial DNA alterations underlie an irreversible shift to aerobic glycolysis in fumarate hydratase-deficient renal cancer.
    Crooks DR; Maio N; Lang M; Ricketts CJ; Vocke CD; Gurram S; Turan S; Kim YY; Cawthon GM; Sohelian F; De Val N; Pfeiffer RM; Jailwala P; Tandon M; Tran B; Fan TW; Lane AN; Ried T; Wangsa D; Malayeri AA; Merino MJ; Yang Y; Meier JL; Ball MW; Rouault TA; Srinivasan R; Linehan WM
    Sci Signal; 2021 Jan; 14(664):. PubMed ID: 33402335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [From gene to disease; cutaneous leiomyomatosis].
    Badeloe S; van Geel M; van Steensel MA; Steijlen PM; Poblete-Gutiérrez P; Frank JA
    Ned Tijdschr Geneeskd; 2007 Feb; 151(5):300-4. PubMed ID: 17326474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutation screening of fumarate hydratase by multiplex ligation-dependent probe amplification: detection of exonic deletion in a patient with leiomyomatosis and renal cell cancer.
    Ahvenainen T; Lehtonen HJ; Lehtonen R; Vahteristo P; Aittomäki K; Baynam G; Dommering C; Eng C; Gruber SB; Grönberg H; Harvima R; Herva R; Hietala M; Kujala M; Kääriäinen H; Sunde L; Vierimaa O; Pollard PJ; Tomlinson IP; Björck E; Aaltonen LA; Launonen V
    Cancer Genet Cytogenet; 2008 Jun; 183(2):83-8. PubMed ID: 18503824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence for a founder effect of the germline fumarate hydratase gene mutation R58P causing hereditary leiomyomatosis and renal cell cancer (HLRCC).
    Heinritz W; Paasch U; Sticherling M; Wittekind C; Simon JC; Froster UG; Renner R
    Ann Hum Genet; 2008 Jan; 72(Pt 1):35-40. PubMed ID: 17908262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.